Home
About
Technology
Pipeline
- Clinical Pipeline
- Clinical Trials
Investor Centre
Contact

Conference Presentations

View by year:

24 Jan 2024

2024 ASCO Gastrointestinal Cancers Symposium

Oncolytic Virus CF33-hNIS Monotherapy for the Treatment of Gastrointestinal Malignancies (presented by Dr Daneng Li and Grey Wilkinson)

13 Dec 2023

The 8th Oncolytic Virotherapy Summit

ONCARLYTICS: A first-in-class CD19-expressing OV for use in solid tumors (presented by Grey Wilkinson)

01 Oct 2022

CF33-CD19t oncolytic virus (onCARlytics) in combination with off-the-shelf allogeneic CyCART-19 T cells targeting de novo CD19+ solid tumors

01 Oct 2022

CF33-CD19t oncolytic virus (onCARlytics) targets hepatocellular carcinoma (HCC) and in combination with Artemis® CD19 T cells results in significant tumor killing

01 Oct 2022

Combination immunotherapy using a novel chimeric oncolytic virus to redirect CD19 bispecific T cell

1 2

Investor Centre

Welcome to Imugene Investor Centre
ASX Announcements
Investor Presentations
Conference Presentations
Financial Reports
Analyst Coverage
ESG Reports
Media
Videos
Newsletters

Investor Centre

Welcome to Imugene Investor Centre
ASX Announcements
Investor Presentations
Conference Presentations
Financial Reports
Analyst Coverage
ESG Reports
Media
Videos
Newsletters

Subscribe to our email newsletter to receive the latest news and updates

First Name(Required)

Last Name(Required)

Email(Required)

Home
Contact

About

Technology
Pipeline
- Clinical Pipeline
- Clinical Trials

Investor Centre

© 2026 Imugene Limited

Website by Argon